Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1

The conventional therapy for the management of Herpes Simplex Virus Type 1 (HSV-1) infections mainly comprises acyclovir (ACV) and other nucleoside analogues. A common outcome of this treatment is the emergence of resistant viral strains, principally when immunosuppressed patients are involved. Thus...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alche, Laura Edith, Ramirez, Javier Alberto, Barquero, Andrea Alejandra
Publicado: 2015
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01663542_v122_n_p55_Davola
http://hdl.handle.net/20.500.12110/paper_01663542_v122_n_p55_Davola
Aporte de:
id paper:paper_01663542_v122_n_p55_Davola
record_format dspace
spelling paper:paper_01663542_v122_n_p55_Davola2023-06-08T15:15:38Z Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1 Alche, Laura Edith Ramirez, Javier Alberto Barquero, Andrea Alejandra Acyclovir resistant Antiviral Herpes simplex type I Non-natural side chains Pregnenolone analogs aciclovir glucocorticoid pregnenolone derivative aciclovir antivirus agent pregnenolone animal cell antiviral activity antiviral resistance Article controlled study cytotoxicity drug synthesis Herpes simplex virus 1 nonhuman priority journal Vero cell line virus isolation virus strain analogs and derivatives animal Chlorocebus aethiops drug development drug effects growth, development and aging herpes simplex Herpes simplex virus 1 microbial sensitivity test synthesis Human herpesvirus 1 Acyclovir Animals Antiviral Agents Cercopithecus aethiops Drug Discovery Drug Resistance, Viral Herpes Simplex Herpesvirus 1, Human Microbial Sensitivity Tests Pregnenolone Vero Cells The conventional therapy for the management of Herpes Simplex Virus Type 1 (HSV-1) infections mainly comprises acyclovir (ACV) and other nucleoside analogues. A common outcome of this treatment is the emergence of resistant viral strains, principally when immunosuppressed patients are involved. Thus, the development of new antiherpetic compounds remains as a central challenge. In this work we describe the synthesis and the in vitro antiherpetic activity of a new family of steroidal compounds derived from the endogenous hormone pregnenolone. Some of these derivatives showed a remarkable inhibitory effect on HSV-1 spread both on wild type and ACV-resistant strains. The results also show that these compounds seem to interfere with the late steps of the viral cycle. © 2015 Elsevier B.V. Fil:Alché, L.E. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Ramírez, J.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Barquero, A.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2015 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01663542_v122_n_p55_Davola http://hdl.handle.net/20.500.12110/paper_01663542_v122_n_p55_Davola
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Acyclovir resistant
Antiviral
Herpes simplex type I
Non-natural side chains
Pregnenolone analogs
aciclovir
glucocorticoid
pregnenolone derivative
aciclovir
antivirus agent
pregnenolone
animal cell
antiviral activity
antiviral resistance
Article
controlled study
cytotoxicity
drug synthesis
Herpes simplex virus 1
nonhuman
priority journal
Vero cell line
virus isolation
virus strain
analogs and derivatives
animal
Chlorocebus aethiops
drug development
drug effects
growth, development and aging
herpes simplex
Herpes simplex virus 1
microbial sensitivity test
synthesis
Human herpesvirus 1
Acyclovir
Animals
Antiviral Agents
Cercopithecus aethiops
Drug Discovery
Drug Resistance, Viral
Herpes Simplex
Herpesvirus 1, Human
Microbial Sensitivity Tests
Pregnenolone
Vero Cells
spellingShingle Acyclovir resistant
Antiviral
Herpes simplex type I
Non-natural side chains
Pregnenolone analogs
aciclovir
glucocorticoid
pregnenolone derivative
aciclovir
antivirus agent
pregnenolone
animal cell
antiviral activity
antiviral resistance
Article
controlled study
cytotoxicity
drug synthesis
Herpes simplex virus 1
nonhuman
priority journal
Vero cell line
virus isolation
virus strain
analogs and derivatives
animal
Chlorocebus aethiops
drug development
drug effects
growth, development and aging
herpes simplex
Herpes simplex virus 1
microbial sensitivity test
synthesis
Human herpesvirus 1
Acyclovir
Animals
Antiviral Agents
Cercopithecus aethiops
Drug Discovery
Drug Resistance, Viral
Herpes Simplex
Herpesvirus 1, Human
Microbial Sensitivity Tests
Pregnenolone
Vero Cells
Alche, Laura Edith
Ramirez, Javier Alberto
Barquero, Andrea Alejandra
Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1
topic_facet Acyclovir resistant
Antiviral
Herpes simplex type I
Non-natural side chains
Pregnenolone analogs
aciclovir
glucocorticoid
pregnenolone derivative
aciclovir
antivirus agent
pregnenolone
animal cell
antiviral activity
antiviral resistance
Article
controlled study
cytotoxicity
drug synthesis
Herpes simplex virus 1
nonhuman
priority journal
Vero cell line
virus isolation
virus strain
analogs and derivatives
animal
Chlorocebus aethiops
drug development
drug effects
growth, development and aging
herpes simplex
Herpes simplex virus 1
microbial sensitivity test
synthesis
Human herpesvirus 1
Acyclovir
Animals
Antiviral Agents
Cercopithecus aethiops
Drug Discovery
Drug Resistance, Viral
Herpes Simplex
Herpesvirus 1, Human
Microbial Sensitivity Tests
Pregnenolone
Vero Cells
description The conventional therapy for the management of Herpes Simplex Virus Type 1 (HSV-1) infections mainly comprises acyclovir (ACV) and other nucleoside analogues. A common outcome of this treatment is the emergence of resistant viral strains, principally when immunosuppressed patients are involved. Thus, the development of new antiherpetic compounds remains as a central challenge. In this work we describe the synthesis and the in vitro antiherpetic activity of a new family of steroidal compounds derived from the endogenous hormone pregnenolone. Some of these derivatives showed a remarkable inhibitory effect on HSV-1 spread both on wild type and ACV-resistant strains. The results also show that these compounds seem to interfere with the late steps of the viral cycle. © 2015 Elsevier B.V.
author Alche, Laura Edith
Ramirez, Javier Alberto
Barquero, Andrea Alejandra
author_facet Alche, Laura Edith
Ramirez, Javier Alberto
Barquero, Andrea Alejandra
author_sort Alche, Laura Edith
title Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1
title_short Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1
title_full Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1
title_fullStr Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1
title_full_unstemmed Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1
title_sort synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of herpes simplex virus type 1
publishDate 2015
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01663542_v122_n_p55_Davola
http://hdl.handle.net/20.500.12110/paper_01663542_v122_n_p55_Davola
work_keys_str_mv AT alchelauraedith syntheticpregnenolonederivativesasantiviralagentsagainstacyclovirresistantisolatesofherpessimplexvirustype1
AT ramirezjavieralberto syntheticpregnenolonederivativesasantiviralagentsagainstacyclovirresistantisolatesofherpessimplexvirustype1
AT barqueroandreaalejandra syntheticpregnenolonederivativesasantiviralagentsagainstacyclovirresistantisolatesofherpessimplexvirustype1
_version_ 1768546624853770240